Metropolitan Life Insurance Company (MetLife)’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,573
| Closed | -$381K | – | 1522 |
|
|
2024
Q1 | $381K | Buy |
5,573
+252
| +5% | +$17.2K | 0.02% | 523 |
|
|
2023
Q4 | $334K | Sell |
5,321
-117
| -2% | -$7.35K | 0.02% | 551 |
|
|
2023
Q3 | $277K | Buy |
5,438
+418
| +8% | +$21.3K | 0.01% | 569 |
|
|
2023
Q2 | $251K | Buy |
5,020
+1,042
| +26% | +$52K | 0.01% | 590 |
|
|
2023
Q1 | $149K | Sell |
3,978
-453
| -10% | -$17K | 0.01% | 790 |
|
|
2022
Q4 | $212K | Buy |
4,431
+1,237
| +39% | +$59.3K | 0.01% | 685 |
|
|
2022
Q3 | $76.7K | Hold |
3,194
| – | – | ﹤0.01% | 1175 |
|
|
2022
Q2 | $69.5K | Buy |
3,194
+520
| +19% | +$11.3K | ﹤0.01% | 1295 |
|
|
2022
Q1 | $64.6K | Sell |
2,674
-8,743
| -77% | -$211K | ﹤0.01% | 1449 |
|
|
2021
Q4 | $272K | Hold |
11,417
| – | – | ﹤0.01% | 1801 |
|
|
2021
Q3 | $290K | Hold |
11,417
| – | – | ﹤0.01% | 1801 |
|
|
2021
Q2 | $257K | Buy |
11,417
+2,861
| +33% | +$64.4K | ﹤0.01% | 1970 |
|
|
2021
Q1 | $169K | Buy |
8,556
+3,159
| +59% | +$62.4K | ﹤0.01% | 2143 |
|
|
2020
Q4 | $143K | Hold |
5,397
| – | – | ﹤0.01% | 2164 |
|
|
2020
Q3 | $267K | Buy |
+5,397
| New | +$267K | ﹤0.01% | 1600 |
|